Comparison of Efficacy & Tolerability Between Ganfort vs Krytantek in Mexican Patients With Primary Open-Angle Glaucoma (POAG) or Ocular Hypertension (OHT)
Study Identifier
ALLE-GANFORT-001-4-2011
CT.gov Identifier
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact
Study Complete
Study Details
Medical Condition
Study Drug
Phase
N/A
Sex
Female & Male
Age
N/A
Protocol Summary
The objective of this phase IV clinical multi-center trial will be to compare the efficacy and safety of Ganforti® versus Krytantek®, using a cross-over design during a six month period (including a one-month wash-in period) in POAG and OH patients.
Study Locations
Location
Status
Location
Global Galucoma Institute
Guadalajara, Jalisco, Mexico
Status
Not applicable
Location
Asociación Para Evitar La Ceguera en México
Mexico City, Mexico City, Mexico
Status
Not applicable
Location
Hospital de Nuestra Señora de la Luz
Mexico City, Mexico City, Mexico
Status
Not applicable
Location
Instituto Oftalmológico Conde de Valencian
Mexico City, Mexico City, Mexico
Status
Not applicable